Dong-A Socio Holdings Co., Ltd. (KRX:000640)

South Korea flag South Korea · Delayed Price · Currency is KRW
116,900
-2,700 (-2.26%)
At close: Feb 27, 2026
20.17%
Market Cap 752.34B
Revenue (ttm) 1.40T
Net Income (ttm) 107.66B
Shares Out 6.44M
EPS (ttm) 16,724.68
PE Ratio 6.99
Forward PE 6.98
Dividend 1,650.49 (1.41%)
Ex-Dividend Date Mar 11, 2026
Volume 8,826
Average Volume 16,879
Open 119,700
Previous Close 119,600
Day's Range 116,200 - 120,600
52-Week Range 94,078 - 125,500
Beta -0.08
RSI 60.16
Earnings Date Feb 9, 2026

About Dong-A Socio Holdings

Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments. The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of Stelara in Phase 3 clinical trial; DA-1241 in Phase 2 clinical trial for the treatment of non-alcoholic steatohepatitis; DA-1726 in Phase 1 clinical tri... [Read more]

Sector Healthcare
Founded 1932
Employees 83
Stock Exchange Korea Stock Exchange
Ticker Symbol 000640
Full Company Profile

Financial Performance

In 2024, Dong-A Socio Holdings's revenue was 1.33 trillion, an increase of 17.78% compared to the previous year's 1.13 trillion. Earnings were 58.02 billion, an increase of 0.06%.

Financial Statements

News

There is no news available yet.